Skip to content

Axogen AXGN EBITDA margin

EBITDA margin at other companies

Baxter International logo
Baxter InternationalBAX
5.9%-6.2pp
Stryker logo
StrykerSYK
24.6%+4.7pp
LeMaitre Vascular logo
LeMaitre VascularLMAT
32.6%+4.9pp
Medtronic logo
MedtronicMDT
25.9%-0.4pp

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.26B+110%

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Calculated from Axogen’s reported figures.

Based on trailing twelve months.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's EBITDA margin?
Axogen (AXGN) reported EBITDA margin of -1% in Q1 2026.
What is the long-term trend for Axogen's EBITDA margin?
Over 4 years (2020 to 2025), Axogen's EBITDA margin has grown at a -59.3% compound annual growth rate (CAGR), from -19.3% to -0.5%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.